Libya vs Serbia: Cause of death, by non-communicable diseases, ages 60+, male
Libya
67.7%
in 2021
Serbia
68.6%
in 2021
Libya rank
98th
Serbia rank
95th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Libya
- Serbia
How they compare
Serbia currently reports 68.6% against 67.7% in Libya, a difference of 0.9%.
Across all 6 years both countries report, Serbia has been ahead every year.
Libya ranks 98th and Serbia ranks 95th of 185 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 88.8% | 95.1% | 6.3% | Serbia |
| 2010s | 89.7% | 95.1% | 5.4% | Serbia |
| 2020s | 73.6% | 74.8% | 1.3% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Libya or Serbia?
- Serbia, at 68.6% against 67.7% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Libya and Serbia?
- 0.9%, with Serbia ahead.
- How many years of comparable data are there for Libya and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Libya and Serbia rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Libya ranks 98th and Serbia ranks 95th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.